search
Back to results

The Effects of Physiologic Oxygen Tension on Clinical In Vitro Fertilization Outcomes (PhOx)

Primary Purpose

Pregnancy, Infertility

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Atmospheric oxygen tension
Physiologic oxygen tension
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pregnancy focused on measuring Pregnancy, Infertility, Physiologic Oxygen Tension, Atmospheric Oxygen Tension

Eligibility Criteria

18 Years - 42 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

The critical inclusion criteria will be the diagnosis of infertility and the need for in vitro fertilization as determined by the treating clinician. (We do not plan to alter the standard of care for the indication for IVF at any of the sites.)

  • Couple's age must be between 18 and 42 years old
  • Patient and partner are scheduled to undergo in vitro fertilization for treatment of infertility
  • Couple able to participate in a research project and A) Able to understand study requirements B) Willing to sign informed consent C) Able to return for required follow-up D) Have access to telephone

Exclusion Criteria:

Critical exclusion criteria for this trial will be medical conditions which may complicate treatment or no plans to undergo embryo transfer, as in patients banking embryos prior to cancer therapy. In addition, donor egg and frozen embryo transfer cycles will be excluded.

  • Medical contraindication to egg retrieval or pregnancy
  • Inability to participate in a research project (Non-English speaking or unable to read or write and/or concurrent participation in any other interventional trial)
  • Couple with more than three previous failed IVF cycles
  • Donor egg and frozen embryo transfer cycles

Sites / Locations

  • University of California, San Francisco
  • Yale University
  • University of Connecticut
  • University of Pennsylvania

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

atmospheric (20%) oxygen tension

physiologic (5%) oxygen tension

Arm Description

Couples will have their gametes and embryos placed in the currently widely used atmospheric (20%) oxygen atmosphere

Couples will have their gametes and embryos placed in a physiologic (5%) oxygen atmosphere

Outcomes

Primary Outcome Measures

The primary outcome is live birth rate.

Secondary Outcome Measures

The impact of treatment on embryo cleavage
The impact of treatment on clinical pregnancy
The impact of treatment on multiple pregnancy
The impact of treatment on miscarriage

Full Information

First Posted
November 6, 2009
Last Updated
May 5, 2017
Sponsor
Yale University
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Pennsylvania, University of California, San Francisco, University of Connecticut
search

1. Study Identification

Unique Protocol Identification Number
NCT01010386
Brief Title
The Effects of Physiologic Oxygen Tension on Clinical In Vitro Fertilization Outcomes
Acronym
PhOx
Official Title
A Prospective, Randomized, Double-Blind, Controlled Clinical Trial of the Effects of Oxygen Tension on Clinical In Vitro Fertilization Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Yale University
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Pennsylvania, University of California, San Francisco, University of Connecticut

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Primary Aim Evaluate whether human embryo exposure to physiologic levels of oxygen during culture improves the percentage of women who deliver a baby following in vitro fertilization and embryo transfer. Hypothesis to be tested: Physiologic oxygen tension during embryo culture, which approximates the oxygen tension in the fallopian tube and uterus, improves live birth rate in clinical In Vitro Fertilization Embryo Transfer (IVF-ET). Secondary Aims Evaluate whether human embryo exposure to physiologic levels of oxygen during culture during in vitro fertilization and embryo transfer improves embryo cleavage improves clinical pregnancy rate reduces multiple pregnancy rate reduces miscarriage rate Hypothesis to be tested: Physiologic oxygen tension during embryo culture, which approximates the oxygen tension in the fallopian tube and uterus, improves embryo cleavage and clinical pregnancy rates and reduces miscarriage rates in clinical IVF-ET.
Detailed Description
Study Design This will be a multi-center, prospective, double-blind clinical trial of physiologic (5%) oxygen tension in culture media vs. standard of care, atmospheric (SOC, 20%) oxygen tension with 840 eligible couples recruited to participate. The randomization scheme will be coordinated through the central data coordinating center (DCC-Yale) and the randomization will be stratified by age group of the woman (18-34, 35-37, 38-40 and 40-42) and each participating site. Treatment Couples will be randomized to either have their gametes and embryos placed in a physiologic (5%) oxygen atmosphere or in the currently widely used atmospheric (20%) oxygen atmosphere.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pregnancy, Infertility
Keywords
Pregnancy, Infertility, Physiologic Oxygen Tension, Atmospheric Oxygen Tension

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
851 (Actual)

8. Arms, Groups, and Interventions

Arm Title
atmospheric (20%) oxygen tension
Arm Type
Placebo Comparator
Arm Description
Couples will have their gametes and embryos placed in the currently widely used atmospheric (20%) oxygen atmosphere
Arm Title
physiologic (5%) oxygen tension
Arm Type
Active Comparator
Arm Description
Couples will have their gametes and embryos placed in a physiologic (5%) oxygen atmosphere
Intervention Type
Procedure
Intervention Name(s)
Atmospheric oxygen tension
Intervention Description
Couples will have their gametes and embryos placed in the currently widely used atmospheric (20%) oxygen atmosphere
Intervention Type
Procedure
Intervention Name(s)
Physiologic oxygen tension
Intervention Description
Couples will have their gametes and embryos placed in a physiologic (5%) oxygen atmosphere
Primary Outcome Measure Information:
Title
The primary outcome is live birth rate.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
The impact of treatment on embryo cleavage
Time Frame
2 years
Title
The impact of treatment on clinical pregnancy
Time Frame
2 years
Title
The impact of treatment on multiple pregnancy
Time Frame
2 years
Title
The impact of treatment on miscarriage
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The critical inclusion criteria will be the diagnosis of infertility and the need for in vitro fertilization as determined by the treating clinician. (We do not plan to alter the standard of care for the indication for IVF at any of the sites.) Couple's age must be between 18 and 42 years old Patient and partner are scheduled to undergo in vitro fertilization for treatment of infertility Couple able to participate in a research project and A) Able to understand study requirements B) Willing to sign informed consent C) Able to return for required follow-up D) Have access to telephone Exclusion Criteria: Critical exclusion criteria for this trial will be medical conditions which may complicate treatment or no plans to undergo embryo transfer, as in patients banking embryos prior to cancer therapy. In addition, donor egg and frozen embryo transfer cycles will be excluded. Medical contraindication to egg retrieval or pregnancy Inability to participate in a research project (Non-English speaking or unable to read or write and/or concurrent participation in any other interventional trial) Couple with more than three previous failed IVF cycles Donor egg and frozen embryo transfer cycles
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Esther Eisenberg, MD, MPH
Organizational Affiliation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Nanette Santoro, MD
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Christos Coutifaris, MD, PhD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marcelle Cedars, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
John Nulsen, MD
Organizational Affiliation
University of Connecticut
Official's Role
Study Director
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94115
Country
United States
Facility Name
Yale University
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06511
Country
United States
Facility Name
University of Connecticut
City
Storrs
State/Province
Connecticut
ZIP/Postal Code
06269
Country
United States
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Effects of Physiologic Oxygen Tension on Clinical In Vitro Fertilization Outcomes

We'll reach out to this number within 24 hrs